Brivaracetam has been discontinued (DEA controlled susbtance). Brivaracetam (formerly known as UCB-34714 and UCB 34714; Briviact), is a chemical analogue of levetiracetam, is a racetam derivative with anticonvulsant/antiepileptic effects. It was approved in 2016 for the treatment of epilepsy.

纯度：≥98%

CAS：357336-20-0